aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Akura Medical, founded with the mission to revolutionize the treatment of venous thromboembolisms (VTE), focuses on developing next-generation thrombectomy devices. Their core vision is to provide efficient and user-friendly solutions for the removal of blood clots, specifically targeting conditions like Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). By addressing the limitations of current treatments, Akura Medical aims to improve patient outcomes and reduce the significant mortality associated with VTE.
Notable figures affiliated with Akura Medical include experienced professionals in the medical device industry, though specific names are not provided. The company has made significant strides in the field of thrombectomy, contributing to the advancement of cardiovascular health. Their innovative approach has garnered attention from investors focused on life-saving medical technologies. Akura Medical's impact is underscored by its commitment to addressing a critical need in cardiovascular care, aiming to reduce the 100,000 annual deaths in the U.S. attributed to VTE.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Medical Devices
Technology
HealthTech
Tags
Biotech
Model Types
Hardware
Revenue Type(s)
Transactional
Customer Type(s)
Enterprise
Geographic Exposure
United States
When was Akura Medical founded?
Akura Medical was founded in 2019.
Where is Akura Medical's headquarters located?
Akura Medical's headquarters is located in Campbell, CA, US.
When was Akura Medical's last funding round?
Akura Medical's most recent funding round was for $35M (USD) in October 2023.
How many employees does Akura Medical have?
Akura Medical has 5 employees as of Feb 5, 2024.
How much has Akura Medical raised to-date?
As of July 05, 2023, Akura Medical has raised a total of $60M (USD) since Oct 3, 2023.
Add Comparison
Total Raised to Date
$60M
USD
Last Update Oct 3, 2023
Last Deal Details
$35M
USD
Oct 3, 2023
Series B
Total Employees Over Time
5
As of Feb 2024
Akura Medical Address
590 Division Street
Campbell,
California
95008
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts